Computational discovery of Ethyl gallate as a novel toll-interacting-protein (TOLLIP) interactor: a therapeutic strategy against paraquat-induced toxicity

利用计算方法发现没食子酸乙酯是一种新型的Toll相互作用蛋白(TOLLIP)相互作用蛋白:对抗百草枯诱导毒性的治疗策略

阅读:1

Abstract

Paraquat (PQ) is a highly toxic herbicide that is lethal and causes fatal multi-organ toxicity in humans, as there are no effective treatments available. Despite extensive studies on new therapeutic targets and lead compounds, the existing approaches for treating PQ-induced toxicity remain inadequate and challenging, highlighting the urgent need for curative therapeutic approaches of great significance. This study uses the computational approach to identify the potential phytoconstituent-based antioxidant exhibiting the potential binding affinity with the Toll-interacting protein (TOLLIP). Initially, using molecular docking, mechanics-generalized born surface area (MM/GBSA) binding energy calculation, and ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity), a total of 89 phytoconstituents were evaluated for binding affinity to the TOLLIP. The five compounds Arbutin, Coumaric acid, Ethyl gallate, Ferulic acid, and Vanillic acid with significant binding affinity and pharmacokinetic properties, were further subjected to molecular dynamic simulation, trajectory analysis (RMSD, RMSF, Radius of gyration), binding free energy, PCA, DCCM. Our extensive computational analysis identified the Ethyl gallate-TOLLIP complex as a promising candidate, characterized by exceptional structural stability, minimal fluctuation, and the highest negative binding free energy. Therefore, Ethyl gallate may act as a potent therapeutic agent for mitigating paraquat-induced toxicity by targeting TOLLIP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40203-025-00455-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。